Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 212,476 | 188,914 | 154,512 | 104,941 | 68,474 |
| Cost of Goods | 97,464 | 84,978 | 70,603 | 49,979 | 30,223 |
| Gross Profit | 115,012 | 103,936 | 83,909 | 54,962 | 38,251 |
| Operating Expenses | 110,272 | 99,801 | 80,122 | 53,364 | 37,063 |
| Operating Income | 5,204 | 5,113 | 4,390 | 2,577 | 1,411 |
| Interest Expense | 103 | 401 | 943 | 3,047 | 2,007 |
| Other Income | 149 | 1,261 | 71 | -1,951 | -862 |
| Pre-tax Income | 5,250 | 5,973 | 3,518 | -2,421 | -1,458 |
| Income Tax | 2,314 | 1,011 | 480 | 534 | 294 |
| Net Income Continuous | 2,936 | 4,962 | 3,038 | -2,955 | -1,752 |
| Net Income | $2,936 | $4,962 | $3,038 | $-2,955 | $-1,752 |
| EPS Basic Total Ops | 0.08 | 0.13 | 0.08 | -0.31 | -1.26 |
| EPS Basic Continuous Ops | 0.08 | 0.13 | 0.08 | -0.18 | -0.40 |
| EPS Diluted Total Ops | 0.07 | 0.12 | 0.08 | -0.31 | -1.26 |
| EPS Diluted Continuous Ops | 0.07 | 0.12 | 0.08 | -0.18 | -0.40 |
| EPS Diluted Before Non-Recurring Items | 0.25 | 0.32 | 0.27 | -0.18 | -1.06 |
| EBITDA(a) | $15,427 | $16,076 | $13,932 | $8,559 | $5,013 |